Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
Eneurologicalsci|December 21, 2017
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Maria José Catalán, Angelo Antonini, Matilde Calopa, et al.
Expert Review of Neurotherapeutics|December 31, 2025
The challenges with the identification of Parkinson's disease subtypesLeonardo Rigon, Karolina Poplawska-Domaszewicz, Vinod Metta, et al.
Parkinsonism & Related Disorders|October 18, 2017
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registryAngelo Antonini, Werner Poewe, K Ray Chaudhuri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 20, 2025
Conversion between NMSS and MDS-NMS in Parkinson's DiseaseMichela Garon, José-Manuel Rojo-Albuin, K Ray Chaudhuri, et al.
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
BMC Neurology|March 13, 2022
Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trialK Ray Chaudhuri, Per Odin, Joaquim J Ferreira, et al.
Parkinson'S Disease|December 23, 2011
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation projectVinod Metta, Kartik Logishetty, P Martinez-Martin, et al.
Journal of Neurology|January 13, 2012
Gender-related differences in the burden of non-motor symptoms in Parkinson's diseasePablo Martinez-Martin, Cristian Falup Pecurariu, Per Odin, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Journal of Parkinson'S Disease|August 14, 2022
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-UpK Ray Chaudhuri, Angelo Antonini, Rajesh Pahwa, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
Eneurologicalsci|December 21, 2017
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Maria José Catalán, Angelo Antonini, Matilde Calopa, et al.
Expert Review of Neurotherapeutics|December 31, 2025
The challenges with the identification of Parkinson's disease subtypesLeonardo Rigon, Karolina Poplawska-Domaszewicz, Vinod Metta, et al.
Parkinsonism & Related Disorders|October 18, 2017
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registryAngelo Antonini, Werner Poewe, K Ray Chaudhuri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 20, 2025
Conversion between NMSS and MDS-NMS in Parkinson's DiseaseMichela Garon, José-Manuel Rojo-Albuin, K Ray Chaudhuri, et al.
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
BMC Neurology|March 13, 2022
Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trialK Ray Chaudhuri, Per Odin, Joaquim J Ferreira, et al.
Parkinson'S Disease|December 23, 2011
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation projectVinod Metta, Kartik Logishetty, P Martinez-Martin, et al.
Journal of Neurology|January 13, 2012
Gender-related differences in the burden of non-motor symptoms in Parkinson's diseasePablo Martinez-Martin, Cristian Falup Pecurariu, Per Odin, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Journal of Parkinson'S Disease|August 14, 2022
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-UpK Ray Chaudhuri, Angelo Antonini, Rajesh Pahwa, et al.
Pageof 17